Pentoxifylline (PTX) - an Alternative Treatment in Graves' Ophthalmopathy (Inactive Phase): Assessment by a Disease Specific Quality of Life Questionnaire and by Exophthalmometry in a Prospective Randomized Trial-Reference-Cited by-同舟云学术

Pentoxifylline (PTX) - an Alternative Treatment in Graves' Ophthalmopathy (Inactive Phase): Assessment by a Disease Specific Quality of Life Questionnaire and by Exophthalmometry in a Prospective Randomized Trial

Published:2004-07 Issue:4 Volume:14 Page:277-283
ISSN:1120-6721
Container-title:European Journal of Ophthalmology
language:en
Short-container-title:European Journal of Ophthalmology

Author:

Finamor F.E.¹,Martins J.R.M.¹,Nakanami D.²,Paiva E.R.³,Manso P.G.²,Furlanetto R.P.¹

Affiliation:

1. Division of Endocrinology, UNIFESP/EPM, São Paulo - Brazil

2. Department of Ophthalmology, UNIFESP/EPM, São Paulo - Brazil

3. Department of Biostatistics, UNIFESP/EPM, São Paulo - Brazil

Publisher

SAGE Publications

Subject

Ophthalmology,General Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/112067210401400401

Reference40 articles.

1. Development of a disease specific quality of life questionnaire for patients with Graves' ophthalmopathy: the GO-QOL

2. Thyroid-associated eye disease: pathophysiology

3. Association of Visual Impairment with Mobility and Physical Function

4. Functional Status and Quality of Life Measurement Among Ophthalmic Patients

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Review of Pathophysiology and Therapeutic Strategies Targeting TGF-β in Graves’ Ophthalmopathy;Cells;2024-09-05

2. Thyroid-associated ophthalmopathy: the role of oxidative stress;Frontiers in Endocrinology;2024-07-11

3. Redox mechanisms in autoimmune thyroid eye disease;Autoimmunity Reviews;2024-05

4. The Role of Fibrogenesis and Extracellular Matrix Proteins in the Pathogenesis of Graves’ Ophthalmopathy;International Journal of Molecular Sciences;2024-03-14

5. A Randomized Clinical Trial of Intravenous Methylprednisolone With 2 Protocols in Patients With Graves Orbitopathy;The Journal of Clinical Endocrinology & Metabolism;2023-08-14